Profile of vemurafenib-induced severe skin toxicities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Profile of vemurafenib-induced severe skin toxicities

Published:2015-11-02 Issue:2 Volume:30 Page:250-257
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Peuvrel L.¹,Quéreux G.¹,Saint-Jean M.¹,Brocard A.¹,Nguyen J.M.²,Khammari A.¹,Knol A.C.¹,Varey E.¹,Dréno B.¹

Affiliation:

1. Department of Dermatology; Nantes University Hospital; INSERM U892-CNRS U6299; CIC Biothérapie INSERM 0503; Nantes France

2. Department of Epidemiology and Biostatistics; Nantes University Hospital; INSERM U892-CNRS U6299; CIC Biothérapie INSERM 0503; Nantes France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.13443/fullpdf

Reference26 articles.

1. Dabrafenib and its potential for the treatment of metastatic melanoma;Menzies;Drug Des Devel Ther,2012

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients;Boussemart;Ann Oncol,2013

4. Analysis of dermatologic events in vemurafenib-treated patients with melanoma;Lacouture;Oncologist,2013

5. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;N Engl J Med,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valacyclovir as etiology for Drug Reaction with Eosinophilia and Systemic Symptoms: A Case Report;Journal of Community Hospital Internal Medicine Perspectives;2023-11-04

2. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies;American Journal of Clinical Dermatology;2023-07-03

3. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses;Microorganisms;2023-01-30

4. Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma;Journal of the European Academy of Dermatology and Venereology;2021-11-18

5. Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors;Expert Opinion on Drug Metabolism & Toxicology;2021-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3